Jump to:
At-a-glance summary of NICE guidance for NIDDM treatment. Adapted from NICE Short Clinical Guideline 87 (May 2009) - Type 2 Diabetes: Newer agents for blood glucose control in type 2 diabetes [partial update of guideline 66].
To view the chart above, you require Flash.
To print: right-click (Windows) or ctrl + click (Macintosh) on the chart and select 'Print...' from the menu.
KEYWORDS: DPP4 inhibitor | Exenatide | Glitazones | Insulin secretagogues | Metformin | Monitoring | Prandial glucose regulator | Rosiglitazone | Saxagliptin | Sitagliptin | Sulfonylureas
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
A Haymarket Publication © 1957 – 2010
